Clinical Trials - February 17, 2014
NeuroVive reaches milestone in European phase III trial on CicloMulsion
The last of a total of 972 patients have now been enrolled and treated in the company’s ongoing European phase III trial (CIRCUS). In the trial, half of patients received the company’s pharmaceutical CicloMulsion for treating reperfusion injury coincident with myocardial infarction. “We’ve now reached a major milestone in the European cardiac study on NeuroVive’s product […]
Uncategorized - February 14, 2014
Impaired recovery from inflammation linked to Alzheimer’s disease
According to new findings from Karolinska Institutet the final stage of the normal inflammatory process may be disrupted in patients with Alzheimer’s disease. As with other neurodegenerative diseases, Alzheimer’s is characterised by an inflammatory process in the brain. Prolonged inflammation with the release of inflammatory and toxic substances can cause further damage and neuronal death. […]
Uncategorized - February 14, 2014
Umeå chemistry professor gets award
Edlunska priset, handed out by the Royal Swedish handed out by the Royal Swedish Academy of Sciences, goes to Erik Johansson. Johansson is Professor of medical chemistry and biophysics at Umeå University. The motivation for 2014 year’s award is for Johansson’s “development of a groundbreaking biochemistry and fundamental discoveries in eucaryotic DNA replication,” as stated by […]
MedTech Business - February 14, 2014
Bactiguard delivers infection control to Ukraine
The Swedish medtech company has signed Azaris Medical Equipment to introduce Bactiguard’s portfolio for Infection control in Ukraine. The portfolio includes urinary, intravenous and respiratory catheters. “Healthcare Acquired Infections (HAI) is a global problem and with our unique solution, the Bactiguard coating, we will be able to reduce HAI’s in the Ukraine, thereby reducing the […]
In a new job - February 13, 2014
Margareta Ozolins leads AZ Sweden Operations
AstraZeneca announces that Margareta Ozolins has been appointed new manager for Sweden Operations, the company’s production unit in Södertälje. Ozolins takes over after Per Alfredsson who is pursuing a position as manager for Global Supply Chain & Strategy. According to AstraZeneca Margareta Ozolins has a broad professional background and since starting at the company in […]
Agreement - February 13, 2014
Enzymatica starts sale of ColdZyme at airports
The company has signed an agreement with pharmaceutical wholesaler Pharmaxim to distribute ColdZyme at Swedish airports. Air-passengers are an important target group for Enzymatica’s cold treatment spray, claims the company, refering to a US study which has shown that one in five passengers catch a cold after a flight. The company further states that ColdZyme Mouth […]
